BNP Paribas Financial Markets
IMCR icon

BNP Paribas Financial Markets’s Immunocore IMCR Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Sell
16,936
-3,246
-16% -$105K ﹤0.01% 3579
2025
Q4 		$701K Buy
20,182
+445
+2% +$15.7K ﹤0.01% 3368
2025
Q3 		$717K Sell
19,737
-18,439
-48% -$626K ﹤0.01% 3363
2025
Q2 		$1.2M Sell
38,176
-2,145
-5% -$66.6K ﹤0.01% 2799
2025
Q1 		$1.2M Sell
40,321
-152,794
-79% -$4.58M ﹤0.01% 2653
2024
Q4 		$5.7M Buy
+193,115
New +$6.11M ﹤0.01% 1699

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BNP Paribas Financial Markets's IMCR Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Immunocore (IMCR) stake by 16% in Q1 2026, selling an estimated $105K and leaving 16,936 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3579.

BNP Paribas Financial Markets first reported a position in IMCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.7M in Q4 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • BNP Paribas Financial Markets held 16,936 shares of Immunocore worth $511K as of Q1 2026.
  • BNP Paribas Financial Markets sold 3,246 Immunocore shares in Q1 2026, an estimated $105K.
  • Immunocore made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3579 holding.
  • BNP Paribas Financial Markets first reported a position in Immunocore in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Immunocore position peaked at $5.7M in Q4 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.